Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Scheiner

Showing results (51-60 of 203) with videos related to

Pageof 21
Sort By:
Plos One|April 13, 2021
Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver diseaseMichael Eder, Haris Omic, Jana Gorges, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2023
Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, et al.
Nutrients|July 11, 2023
Inadequate Energy Delivery Is Frequent among COVID-19 Patients Requiring ECMO Support and Associated with Increased ICU MortalityMathias Schneeweiss-Gleixner, Bernhard Scheiner, Georg Semmler, et al.
AIDS Patient Care and Stds|May 9, 2019
Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV EradicationDavid Chromy, Mattias Mandorfer, Theresa Bucsics, et al.
Future Oncology (London, England)|April 25, 2023
PETAL protocol: a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinomaPetros Fessas, Bernhard Scheiner, Antonio D'Alessio, et al.
Journal of Gastroenterology|December 14, 2019
The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosisRémy Schwarzer, Thomas Reiberger, Mattias Mandorfer, et al.
Medicine|July 12, 2016
Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective studyBernhard Scheiner, Philipp Schwabl, Sebastian Steiner, et al.
Wiener Klinische Wochenschrift|January 29, 2017
Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in ViennaSebastian Steiner, Theresa Bucsics, Philipp Schwabl, et al.
Hepatology International|October 1, 2020
Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertensionPierre Raeven, Joanna Baron-Stefaniak, Benedikt Simbrunner, et al.
Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.
Pageof 21

Showing results (51-60 of 203) with videos related to

Sort By:
Pageof 21
Plos One|April 13, 2021
Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver diseaseMichael Eder, Haris Omic, Jana Gorges, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2023
Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, et al.
Nutrients|July 11, 2023
Inadequate Energy Delivery Is Frequent among COVID-19 Patients Requiring ECMO Support and Associated with Increased ICU MortalityMathias Schneeweiss-Gleixner, Bernhard Scheiner, Georg Semmler, et al.
AIDS Patient Care and Stds|May 9, 2019
Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV EradicationDavid Chromy, Mattias Mandorfer, Theresa Bucsics, et al.
Future Oncology (London, England)|April 25, 2023
PETAL protocol: a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinomaPetros Fessas, Bernhard Scheiner, Antonio D'Alessio, et al.
Journal of Gastroenterology|December 14, 2019
The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosisRémy Schwarzer, Thomas Reiberger, Mattias Mandorfer, et al.
Medicine|July 12, 2016
Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective studyBernhard Scheiner, Philipp Schwabl, Sebastian Steiner, et al.
Wiener Klinische Wochenschrift|January 29, 2017
Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in ViennaSebastian Steiner, Theresa Bucsics, Philipp Schwabl, et al.
Hepatology International|October 1, 2020
Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertensionPierre Raeven, Joanna Baron-Stefaniak, Benedikt Simbrunner, et al.
Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.
Pageof 21